CRISPRmod CRISPRa lentiviral sgRNA

Predesigned CRISPRa lentiviral sgRNAs for highly efficient gene activation in human and mouse models; available as glycerol stocks and high-titer purified particles.

Genome-wide human and mouse lentiviral sgRNA reagents are specifically designed for CRISPRa. Available as glycerol stocks and high-titer purified particles. When used in conjunction with dCas9-VPR expression, you can leverage the power of the CRISPR-Cas9 system for activation of your favorite gene.

CRISPRmod CRISPRa lentiviral sgRNA

1Start Here

98AEE54A474B4280883C6C7E05B92CA0

Endogenous gene activation with an easy-to-use lentiviral reagent

The CRISPR activation (CRISPRa) system is a unique adaptation of the classical CRISPR-Cas9 gene editing system which utilizes a catalytically deactivated or dead S. pyogenes Cas9 (dCas9) that is fused to one or more transcriptional activators. When paired with a well-designed guide RNA that targets a gene near a promoter region, or trancriptional start site (TSS), it promotes transcriptional activation.

Review our CRISPRa applications page to get an overview of the technology!

Highlights of CRISPRa Lentiviral sgRNA

Individual constructs and sets of 4 are available as high-titer purified lentivirus particles or glycerol stocks.
Designed with a published algorithm by Horlbeck, et. al. that has demonstrated strong levels of gene activation from optimized designs adjacent to one or more transcription start sites.
Purified, concentrated high-titer lentivirus particles can be directly transduced into cells, including difficult-to-transfect cells and lines.
Easily select for edited cells with co-expression of puromycin resistance gene.

Required components for an CRISPRa gene activation experiment using lentiviral sgRNA

A lentiviral expression plasmid or lentiviral particles for CRISPRa dCas9-VPR; a mammalian codon-optimized S. pyogenes deactivated Cas9 fused to VPR activation domains (also compatible with SunTag technology).
A predesigned CRISPRa lentiviral sgRNA for the gene of interest.

Schematic diagram of the CRISPRa lentiviral sgRNA vector

30BD793D6816495C91020F7F76A3702C

In the CRISPRa lentiviral sgRNA vector backbone, the gene-specific guide RNA is expressed under the control of a human U6 promoter, while expression of the puromycin resistance marker (PuroR) is driven from the mouse CMV promoter and allows for rapid selection of cells with integrated CRISPRa sgRNA. The plasmid contains the AmpR resistance marker for growth and selection in E. coli.

Transductions with CRISPRa lentiviral sgRNA particles in different dCas9-VPR cell lines

U2OS, HEK293T, MCF 10A and K562 stably expressing integrated CRISPRa dCas9-VPR were plated at 10,000 cells/well and transduced with CRISPRa sgRNA lentiviral particles targeting POU5F1 or TTN at a MOI of 0.3 to obtain cells with a single integrant. Cells were selected with 2 µg/mL puromycin for 4 days prior to analysis with RT-qPCR. The relative expression of each gene was calculated with the Cq method using GAPDH as the housekeeping gene and normalized to a non-targeting control.

CRISPRa in U2OS cells stably expressing integrated dCas9-VPR was compared using different guide RNAs and delivery methods

CRISPRa using synthetic crRNA:tracrRNA: Cells were plated at 10,000 cells/well and were transfected using DharmaFECT 4 Transfection Reagent with CRISPRa synthetic crRNA:tracrRNA (25 nM) targeting ASCL1, EGFP, POU5F1 and TTN genes. Cells were harvested 72 hours post-transfection and the relative gene expression was calculated using RT-qPCR. The relative expression of each gene was Cq method using GAPDH as the housekeeping gene and normalized to a non-targeting control.

CRISPRa with lentiviral sgRNA transduction: Cells were plated at 10,000 cells/well and were transduced with CRISPRa sgRNA lentiviral particles targeting ASCL1, EGFR, POU5F1 or TTN at a MOI of 0.3 to obtain cells with a single integrant. Cells were selected with 2 µg/mL puromycin for 4 days prior to analysis with RT-qPCR. The relative expression of each gene was calculated with the Cq method using GAPDH as the housekeeping gene and normalized to a non-targeting control.

CRISPRa with lentiviral sgRNA plasmid transfection: cells were plated at 10,000 cells/well and transfected with CRISPRa sgRNA plasmids (100 ng) targeting ASCL1, EGFR, POU5F1 or TTN using DharmaFECT kb Transfection Reagent. Cells were harvested 72 hours post-transfection (without puromycin selection) and the relative gene expression was calculated using RT-qPCR. The relative expression of each gene was Cq method using GAPDH as the housekeeping gene and normalized to a non-targeting control.

Edit-R lentiviral sgRNA for CRISPRa in human induced pluripotent stem cells

(A) Human iPSC (ThermoFisher Cat #A18945) were cultured in feeder-free and serum free culture conditions and visualized for proper morphology on an inverted fluorescent microscope. (B). The human iPSCs were nucleofected according to manufactures protocols using 96-well shuttle solution P3. Three days after nucleofections, cells were harvested, and prepped for RT-qPCR. The relative expression of each gene was calculated with the Cq method using GAPDH as the housekeeping gene and normalized to a non-targeting control.